|
Market Closed -
Bombay S.E.
06:29:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 193.80 INR | -0.51% |
|
+14.30% | +135.62% |
Company Valuation: IOL Chemicals and Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16,608 | 21,222 | 17,964 | 21,354 | 56,886 | - |
| Change | - | 27.78% | -15.35% | 18.87% | 166.39% | - |
| Enterprise Value (EV) | 16,608 | 21,222 | 17,964 | 21,354 | 56,886 | 56,886 |
| Change | - | 27.78% | -15.35% | 18.87% | 166.39% | 0% |
| P/E | 11.9x | 15.8x | 17.8x | 15.5x | 25.8x | 20x |
| PBR | 1.1x | 1.32x | 1.06x | 1.19x | 2.9x | 2.64x |
| PEG | - | -4.68x | -0.7x | 0.4x | 0.4x | 0.7x |
| Capitalization / Revenue | 0.75x | 1x | 0.86x | 0.92x | 2.07x | 1.8x |
| EV / Revenue | 0x | 0x | 0x | 0x | 2.07x | 1.8x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 15.6x | 12.5x |
| EV / EBIT | 0x | 0x | 0x | 0x | 18.2x | 14.2x |
| EV / FCF | -0x | 0x | -0x | 0x | 20.5x | 31.3x |
| FCF Yield | -5.39% | 0.78% | -1.94% | 1.94% | 4.88% | 3.19% |
| Dividend per Share 2 | 0.8 | 1 | 4 | - | - | - |
| Rate of return | 1.41% | 1.38% | 6.54% | - | - | - |
| EPS 2 | 4.74 | 4.58 | 3.44 | 4.69 | 7.5 | 9.7 |
| Distribution rate | 16.9% | 21.8% | 116% | - | - | - |
| Net sales 1 | 22,171 | 21,328 | 20,792 | 23,191 | 27,424 | 31,525 |
| EBITDA 1 | 2,257 | 2,306 | 2,023 | 2,690 | 3,647 | 4,540 |
| EBIT 1 | 2,051 | 1,677 | 1,303 | 1,887 | 3,123 | 3,998 |
| Net income 1 | 1,391 | 1,344 | 1,011 | 1,376 | 2,198 | 2,840 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 56.58 | 72.30 | 61.20 | 72.75 | 193.80 | 193.80 |
| Nbr of stocks (in thousands) | 293,528 | 293,528 | 293,528 | 293,528 | 293,528 | - |
| Announcement Date | 4/28/23 | 5/14/24 | 5/16/25 | 5/20/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 25.97x | - | - | - | 598M | ||
| 33.44x | 12.14x | 24.6x | 0.59% | 1,047B | ||
| 29.82x | - | - | 2% | 646B | ||
| 32.61x | 7.57x | 15.74x | 2.68% | 451B | ||
| 19.99x | 4.75x | 11.76x | 2.79% | 355B | ||
| 21.76x | 5.62x | 13.93x | 2.85% | 291B | ||
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | ||
| 27.35x | 7.07x | 12.56x | 2.33% | 234B | ||
| 13.25x | 4.77x | 9.95x | 3.83% | 203B | ||
| -44.51x | 6.43x | 25.11x | 2.26% | 181B | ||
| Average | 18.05x | 6.58x | 15.74x | 2.38% | 365.99B | |
| Weighted average by Cap. | 24.24x | 8.07x | 17.81x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IOLCP Stock
- Valuation IOL Chemicals and Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















